trimethyloxamine has been researched along with Ischemic Stroke in 14 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 9.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
| "Patients with higher choline and betaine levels had lower risk of cognitive impairment after ischemic stroke, supporting promising prognostic roles of choline pathway nutrients for poststroke cognitive impairment." | 9.41 | Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke. ( Bu, X; Che, B; Ju, Z; Lu, Z; Qian, S; Wang, A; Xu, T; Zhang, J; Zhang, Y; Zheng, X; Zhong, C, 2021) |
| "Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 5.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
| "Patients with higher choline and betaine levels had lower risk of cognitive impairment after ischemic stroke, supporting promising prognostic roles of choline pathway nutrients for poststroke cognitive impairment." | 5.41 | Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke. ( Bu, X; Che, B; Ju, Z; Lu, Z; Qian, S; Wang, A; Xu, T; Zhang, J; Zhang, Y; Zheng, X; Zhong, C, 2021) |
| "Increased levels of lactic acid, pyruvate, and TMAO may be related to the pathophysiological changes in the minor ischaemic stroke population." | 4.12 | Related factors based on non-targeted metabolomics methods in minor ischaemic stroke. ( Chen, C; Ding, L; Guo, J; Liu, H; Ma, Y; Qiao, X; Wang, J; Wang, M; Yang, T; Zhao, S, 2022) |
| "A total of 64 patients with acute ischemic stroke were randomized into an observation group and a control group, 32 cases in each one." | 3.11 | [ ( Du, XZ; Lei, SQ; Liu, MK; Wang, H; Yuan, B, 2022) |
| "As we know, ischemic stroke is a heterogeneous disease with variable pathogenesis." | 2.82 | Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes. ( Cheng, A; Dai, L; Jing, J; Li, H; Meng, X; Song, B; Wang, A; Wang, Y; Xu, J; Xue, J; Zhao, M; Zheng, L, 2022) |
| " Trimethylamine N-oxide level, Acute ischemic stroke, Early neurological deterioration, NIHSS score." | 1.91 | Utility of Trimethylamine Oxide (TMAO) in Predicting Early Neurological Deterioration after Acute Ischemic Stroke. ( Cheng, H; Kang, Y; Liu, J; Shi, Y; Wan, D; Wang, Y, 2023) |
| "TMAO was associated with lacunar stroke but not other ischemic stroke subtypes in a model adjusted for age, sex, hypertension, diabetes, and smoking (OR, 1." | 1.91 | Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke. ( Ament, Z; Bevers, MB; Bhave, VM; Couch, CA; Garcia Guarniz, AL; Irvin, MR; Kijpaisalratana, N; Kimberly, WT, 2023) |
| "A total of 196 patients with ischaemic stroke and 100 controls were included between February 2018 and April 2019." | 1.56 | Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days. ( Hauke, J; Mundiyanapurath, S; Nürnberg, C; Okun, JG; Ringleb, PA; Schneider, C; Schwarz, KV; Ungerer, M; Zorn, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 14 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Cheng, A | 1 |
| Song, B | 1 |
| Zhao, M | 1 |
| Xue, J | 1 |
| Wang, A | 2 |
| Dai, L | 1 |
| Jing, J | 1 |
| Meng, X | 1 |
| Li, H | 1 |
| Zheng, L | 1 |
| Wang, Y | 2 |
| Wang, H | 1 |
| Lei, SQ | 1 |
| Du, XZ | 1 |
| Yuan, B | 1 |
| Liu, MK | 1 |
| Chen, C | 1 |
| Qiao, X | 1 |
| Guo, J | 1 |
| Yang, T | 1 |
| Wang, M | 1 |
| Ma, Y | 1 |
| Zhao, S | 1 |
| Ding, L | 1 |
| Liu, H | 1 |
| Wang, J | 1 |
| Chou, PS | 1 |
| Yang, IH | 1 |
| Kuo, CM | 1 |
| Wu, MN | 1 |
| Lin, TC | 1 |
| Fong, YO | 1 |
| Juan, CH | 1 |
| Lai, CL | 1 |
| Kang, Y | 1 |
| Cheng, H | 1 |
| Shi, Y | 1 |
| Liu, J | 1 |
| Wan, D | 1 |
| Lemaitre, RN | 1 |
| Jensen, PN | 1 |
| Wang, Z | 1 |
| Fretts, AM | 1 |
| Sitlani, CM | 1 |
| Nemet, I | 1 |
| Sotoodehnia, N | 1 |
| de Oliveira Otto, MC | 1 |
| Zhu, W | 1 |
| Budoff, M | 1 |
| Longstreth, WT | 1 |
| Psaty, BM | 1 |
| Siscovick, DS | 1 |
| Hazen, SL | 1 |
| Mozaffarian, D | 1 |
| Kijpaisalratana, N | 1 |
| Ament, Z | 1 |
| Bevers, MB | 1 |
| Bhave, VM | 1 |
| Garcia Guarniz, AL | 1 |
| Couch, CA | 1 |
| Irvin, MR | 1 |
| Kimberly, WT | 1 |
| Hong, Y | 1 |
| Sun, Z | 1 |
| Liu, N | 1 |
| Yang, K | 1 |
| Li, Y | 1 |
| Xu, Q | 1 |
| Guo, Z | 1 |
| Duan, Y | 1 |
| Hu, X | 1 |
| Ren, H | 1 |
| Cao, Y | 1 |
| Schneider, C | 1 |
| Okun, JG | 1 |
| Schwarz, KV | 1 |
| Hauke, J | 1 |
| Zorn, M | 1 |
| Nürnberg, C | 1 |
| Ungerer, M | 1 |
| Ringleb, PA | 1 |
| Mundiyanapurath, S | 1 |
| Sun, T | 1 |
| Zhang, Y | 2 |
| Yin, J | 1 |
| Peng, X | 1 |
| Zhou, L | 1 |
| Huang, S | 1 |
| Wen, Y | 1 |
| Cao, B | 1 |
| Chen, L | 1 |
| Li, X | 1 |
| Yang, W | 1 |
| Tan, A | 1 |
| Cheng, J | 1 |
| Liu, L | 1 |
| Yamashita, T | 1 |
| Yoshida, N | 1 |
| Emoto, T | 1 |
| Hirata, KI | 1 |
| Zhong, C | 1 |
| Lu, Z | 1 |
| Che, B | 1 |
| Qian, S | 1 |
| Zheng, X | 1 |
| Bu, X | 1 |
| Zhang, J | 2 |
| Ju, Z | 1 |
| Xu, T | 1 |
| Wang, L | 1 |
| Cai, J | 1 |
| Lei, A | 1 |
| Liu, C | 1 |
| Lin, R | 1 |
| Jia, L | 1 |
| Fu, Y | 1 |
3 reviews available for trimethyloxamine and Ischemic Stroke
| Article | Year |
|---|---|
Trimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes.
Topics: Atherosclerosis; Humans; Ischemic Stroke; Methylamines; Risk Factors; Stroke | 2022 |
The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis.
Topics: Humans; Ischemic Stroke; Methylamines; Oxides; Stroke | 2023 |
The association between trimethylamine N-oxide levels and ischemic stroke occurrence: a meta-analysis and Mendelian randomization study.
Topics: Genome-Wide Association Study; Humans; Ischemic Stroke; Mendelian Randomization Analysis; Methylamin | 2023 |
3 trials available for trimethyloxamine and Ischemic Stroke
| Article | Year |
|---|---|
[
Topics: Acupuncture Points; Acupuncture Therapy; Brain-Gut Axis; C-Reactive Protein; Humans; Interleukin-17; | 2022 |
Plasma Trimethylamine-
Topics: Aged; Atherosclerosis; Female; Humans; Ischemic Stroke; Methylamines; Oxides; Prospective Studies; R | 2023 |
Choline Pathway Nutrients and Metabolites and Cognitive Impairment After Acute Ischemic Stroke.
Topics: Aged; Antihypertensive Agents; Brain Ischemia; China; Choline; Cognition; Cognition Disorders; Cogni | 2021 |
8 other studies available for trimethyloxamine and Ischemic Stroke
| Article | Year |
|---|---|
Related factors based on non-targeted metabolomics methods in minor ischaemic stroke.
Topics: Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Homocysteine; Humans; Hypertension; I | 2022 |
The Prognostic Biomarkers of Plasma Trimethylamine N-Oxide and Short-Chain Fatty Acids for Recanalization Therapy in Acute Ischemic Stroke.
Topics: Adult; Biomarkers; Brain Ischemia; Fatty Acids, Volatile; Humans; Ischemic Stroke; Prognosis; Prospe | 2023 |
Utility of Trimethylamine Oxide (TMAO) in Predicting Early Neurological Deterioration after Acute Ischemic Stroke.
Topics: Biomarkers; Brain Ischemia; Cohort Studies; Humans; Ischemic Stroke; Stroke; United States | 2023 |
Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke.
Topics: Aged; Betaine; Carnitine; Cerebral Small Vessel Diseases; Choline; Cross-Sectional Studies; Female; | 2023 |
Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days.
Topics: Brain Ischemia; Case-Control Studies; Humans; Ischemic Stroke; Methylamines; Oxides; Prospective Stu | 2020 |
Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
Topics: Age Factors; Alcohol Drinking; Body Mass Index; Case-Control Studies; China; Chromatography, Liquid; | 2021 |
Unraveling the Effects of Trimethylamine N-Oxide on Stroke: "The lower, the better?"
Topics: Betaine; Carnitine; Cholesterol; Choline; Diet Therapy; Gastrointestinal Microbiome; Humans; Ischemi | 2021 |
Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
Topics: Aged; Biomarkers; China; Choline; Cohort Studies; Female; Gastrointestinal Microbiome; Humans; Ische | 2021 |